Form: 20-F

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Exhibit 8.1

Kazia Therapeutics Limited has the following subsidiary companies

 

Subsidiary name

   Shareholding     Company of
incorporation
 

Kazia Laboratories Pty Limited

     100 %      Australia  

Kazia Research Pty Limited

     100 %      Australia  

Kazia Therapeutics Inc

     100 %      USA  

Glioblast Pty Limited

     100 %      Australia